Corr Michael, Walker Andrew, Maxwell Alexander P, McKay Gareth J
Centre for Public Health- Queen's University Belfast, Belfast. UK.
Northern Ireland Foundation School, Belfast, UK.
Transplant Rev (Orlando). 2025 Jan;39(1):100900. doi: 10.1016/j.trre.2024.100900. Epub 2024 Dec 3.
Rejection and graft failure remain common in kidney transplant recipients. Non-adherence to immunosuppressive medications is considered a major contributary factor to reduced long-term graft survival, particularly in younger people. Improvements in clinical practice based on adherence studies has been minimal.
Joanna Briggs' Institute Methodology was used. MedlineALL, Embase, Web of Science Core Collection and Scopus databases were searched from January 2000 through to December 2023. Abstract and full text reviews were undertaken independently by two reviewers. Data was collated using a pre-designed extraction tool.
359 articles met the inclusion criteria. Non-adherence was commonly defined using self-reported questionnaires or pharmacy re-fill rates. Prevalence of non-adherence varied widely. There was little correlation between method of measurement and reported rates of non-adherence. Despite younger age being identified as a risk factor for non-adherence, pooled reported prevalence did not differ significantly in studies reporting prevalence in children, adolescents, or young adults vs. older adults (36.0 % vs. 34.0 %). Interventional studies to detect or improve adherence are highly heterogenous, often report small effects and are limited by the lack of gold-standard methods to measure adherence.
This scoping review outlines the complexities of non-adherence to immunosuppressive medications among kidney transplant recipients, highlighting significant variability in adherence definitions, measurements, and intervention efficacy. Reported non-adherence rates vary widely (2-89 %), underscoring the need for standardisation of the definition of non-adherence in research. Findings suggest that non-adherence to immunosuppressive medication is driven by a mix of demographic, psychosocial, and transplant-specific factors. Future research should prioritise standardised definitions of adherence, validated tools to measure adherence, and focus on clinically significant outcomes in non-adherent populations to develop meaningful, impactful interventions for long-term patient benefit.
移植肾排斥反应和移植失败在肾移植受者中仍然很常见。不坚持服用免疫抑制药物被认为是导致长期移植肾存活降低的一个主要因素,尤其是在年轻人中。基于依从性研究的临床实践改进微乎其微。
采用乔安娜·布里格斯研究所的方法学。检索了2000年1月至2023年12月期间的MedlineALL、Embase、科学引文索引核心合集和Scopus数据库。两名评审员独立进行摘要和全文评审。使用预先设计的提取工具整理数据。
359篇文章符合纳入标准。不依从通常使用自我报告问卷或药房再填充率来定义。不依从的患病率差异很大。测量方法与报告的不依从率之间几乎没有相关性。尽管年轻被确定为不依从的一个风险因素,但在报告儿童、青少年或年轻人与老年人患病率的研究中,汇总报告的患病率没有显著差异(36.0%对34.0%)。检测或改善依从性的干预研究高度异质,通常报告的效果较小,并且受到缺乏测量依从性的金标准方法的限制。
本范围综述概述了肾移植受者不坚持服用免疫抑制药物的复杂性,强调了依从性定义、测量和干预效果方面的显著差异。报告的不依从率差异很大(2%-89%),突出了研究中不依从定义标准化的必要性。研究结果表明,不坚持服用免疫抑制药物是由人口统计学、心理社会和移植特异性因素共同驱动的。未来的研究应优先考虑依从性的标准化定义、验证的测量依从性工具,并关注不依从人群中具有临床意义的结果,以开发有意义、有影响力的干预措施,使患者长期受益。